A new progestogen-estrogen combination for gynecologic therapy and contraception.
D000293:Adolescent; D000328:Adult; D000568:Amenorrhea / Q000188:drug therapy*; D003276:Contraceptives, Oral / Q000009:adverse effects / Q000494:pharmacology*; D004412:Dysmenorrhea; D004715:Endometriosis / Q000188:drug therapy*; D004717:Endometrium / Q000166:cytology / Q000187:drug effects*; D005260:Female; D006801:Humans; D066298:In Vitro Techniques; D007247:Infertility, Female / Q000188:drug therapy*; D008234:Lynestrenol / Q000009:adverse effects / Q000627:therapeutic use*; D008599:Menstruation Disturbances / Q000188:drug therapy*; D008656:Mestranol / Q000009:adverse effects / Q000627:therapeutic use*; D008875:Middle Aged; D010060:Ovulation / Q000187:drug effects*; D011247:Pregnancy
D003276:Contraceptives, Oral; D008656:Mestranol; D008234:Lynestrenol